Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Intellectual Disability
- Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
- Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.
- Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
- Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities
- Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities
- An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
- Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability
- Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
- Neuroimaging GABA Physiology in Fragile X Syndrome
- Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
- A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
- A Trial of Metformin in Individuals With Fragile X Syndrome
- Sulfamethoxazole for the Treatment of Primary PREPL Deficiency
- Down Syndrome Memantine Follow-up Study
- Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
- Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
- Treatment Strategies for Children With Smith-Magenis Syndrome
- Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
- Repetitive Behavior Disorders in People With Severe Mental Retardation
- Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
- Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability
- Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
- Self-Injury: Diagnosis and Treatment
- Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
- Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis